
pmid: 11003771
Over the past decade, there has been a marked increase in the use of arterial conduits to perform coronary artery bypass grafting (CABG).1 The clinical and survival benefits of bilateral internal thoracic artery grafts have established them as conduits of first choice for CABG,2 whereas the radial artery has rapidly become the third most commonly used arterial conduit.3 The radial artery is a versatile conduit, which can be harvested easily and safely, has handling characteristics superior to those of other arterial grafts, and comfortably reaches any coronary target. Several studies3 have reported superior patency of radial artery grafts compared with vein grafts at up to 5 years after CABG. Enthusiasm for widespread use of the radiPHENOXYBENZAMINE PREVENTS SPASM IN RADIAL ARTERY CONDUITS FOR CORONARY ARTERY BYPASS GRAFTING
Pulmonary and Respiratory Medicine, Spasm, Phenoxybenzamine, Vasoconstriction, Vasodilator Agents, Radial Artery, Humans, Surgery, Coronary Artery Bypass, Cardiology and Cardiovascular Medicine
Pulmonary and Respiratory Medicine, Spasm, Phenoxybenzamine, Vasoconstriction, Vasodilator Agents, Radial Artery, Humans, Surgery, Coronary Artery Bypass, Cardiology and Cardiovascular Medicine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 42 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
